nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—SCN1A—migraine	0.222	0.531	CbGaD
Quinidine—SCN2A—migraine	0.196	0.469	CbGaD
Quinidine—SCN1A—Topiramate—migraine	0.0235	0.0566	CbGbCtD
Quinidine—SLC22A4—Verapamil—migraine	0.0219	0.0528	CbGbCtD
Quinidine—ORM1—Propranolol—migraine	0.0208	0.0501	CbGbCtD
Quinidine—ABCB11—Verapamil—migraine	0.0184	0.0442	CbGbCtD
Quinidine—ORM1—Amitriptyline—migraine	0.018	0.0433	CbGbCtD
Quinidine—SLC22A2—Propranolol—migraine	0.0172	0.0414	CbGbCtD
Quinidine—SCN5A—Topiramate—migraine	0.0161	0.0387	CbGbCtD
Quinidine—SCN5A—Verapamil—migraine	0.0155	0.0373	CbGbCtD
Quinidine—SLC22A5—Valproic Acid—migraine	0.0142	0.0343	CbGbCtD
Quinidine—KCNH2—Verapamil—migraine	0.0126	0.0303	CbGbCtD
Quinidine—SLC22A5—Verapamil—migraine	0.0124	0.0298	CbGbCtD
Quinidine—CYP1A1—Propranolol—migraine	0.0117	0.0282	CbGbCtD
Quinidine—SLC22A8—Valproic Acid—migraine	0.0116	0.028	CbGbCtD
Quinidine—SLCO1A2—Verapamil—migraine	0.0116	0.028	CbGbCtD
Quinidine—SLCO1B1—Verapamil—migraine	0.011	0.0264	CbGbCtD
Quinidine—SLC22A1—Verapamil—migraine	0.0103	0.0247	CbGbCtD
Quinidine—CHRM2—Amitriptyline—migraine	0.0102	0.0247	CbGbCtD
Quinidine—ABCC2—Verapamil—migraine	0.00965	0.0232	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Propranolol—migraine	0.00939	0.0226	CbGbCtD
Quinidine—CYP3A7—Propranolol—migraine	0.00939	0.0226	CbGbCtD
Quinidine—CYP2E1—Amitriptyline—migraine	0.00784	0.0189	CbGbCtD
Quinidine—CYP2B6—Amitriptyline—migraine	0.00773	0.0186	CbGbCtD
Quinidine—CYP2B6—Valproic Acid—migraine	0.00705	0.017	CbGbCtD
Quinidine—CYP3A7-CYP3A51P—Verapamil—migraine	0.00644	0.0155	CbGbCtD
Quinidine—CYP3A7—Verapamil—migraine	0.00644	0.0155	CbGbCtD
Quinidine—CYP2B6—Verapamil—migraine	0.00614	0.0148	CbGbCtD
Quinidine—CYP2C8—Amitriptyline—migraine	0.00586	0.0141	CbGbCtD
Quinidine—CYP2C8—Valproic Acid—migraine	0.00534	0.0128	CbGbCtD
Quinidine—CYP1A2—Propranolol—migraine	0.00524	0.0126	CbGbCtD
Quinidine—ABCB1—Timolol—migraine	0.00514	0.0124	CbGbCtD
Quinidine—CYP2D6—Timolol—migraine	0.00485	0.0117	CbGbCtD
Quinidine—CYP2C8—Verapamil—migraine	0.00465	0.0112	CbGbCtD
Quinidine—ABCB1—Propranolol—migraine	0.00458	0.011	CbGbCtD
Quinidine—CYP1A2—Amitriptyline—migraine	0.00453	0.0109	CbGbCtD
Quinidine—CYP2D6—Propranolol—migraine	0.00432	0.0104	CbGbCtD
Quinidine—CYP1A2—Valproic Acid—migraine	0.00413	0.00994	CbGbCtD
Quinidine—CYP2C9—Amitriptyline—migraine	0.00408	0.00983	CbGbCtD
Quinidine—SCN3A—spinal nerve—migraine	0.004	0.182	CbGeAlD
Quinidine—ABCB1—Amitriptyline—migraine	0.00396	0.00954	CbGbCtD
Quinidine—CYP2D6—Amitriptyline—migraine	0.00374	0.00899	CbGbCtD
Quinidine—CYP2C9—Valproic Acid—migraine	0.00372	0.00896	CbGbCtD
Quinidine—CYP1A2—Verapamil—migraine	0.0036	0.00866	CbGbCtD
Quinidine—CYP2C9—Verapamil—migraine	0.00324	0.0078	CbGbCtD
Quinidine—ABCB1—Verapamil—migraine	0.00315	0.00757	CbGbCtD
Quinidine—CYP2D6—Verapamil—migraine	0.00296	0.00713	CbGbCtD
Quinidine—CYP3A4—Propranolol—migraine	0.00275	0.00661	CbGbCtD
Quinidine—CYP3A4—Amitriptyline—migraine	0.00238	0.00572	CbGbCtD
Quinidine—CYP3A4—Valproic Acid—migraine	0.00216	0.00521	CbGbCtD
Quinidine—CYP3A4—Topiramate—migraine	0.00195	0.0047	CbGbCtD
Quinidine—CYP3A4—Verapamil—migraine	0.00188	0.00454	CbGbCtD
Quinidine—SCN3A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00145	0.0293	CbGpPWpGaD
Quinidine—SCN2A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.0014	0.0281	CbGpPWpGaD
Quinidine—SCN3A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.00124	0.0249	CbGpPWpGaD
Quinidine—SCN1A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.00115	0.0231	CbGpPWpGaD
Quinidine—SCN5A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.000947	0.0191	CbGpPWpGaD
Quinidine—KCNK6—Neuronal System—KCNK18—migraine	0.000866	0.0174	CbGpPWpGaD
Quinidine—SCN5A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000805	0.0162	CbGpPWpGaD
Quinidine—KCNK1—Neuronal System—KCNK18—migraine	0.000736	0.0148	CbGpPWpGaD
Quinidine—KCNK6—head—migraine	0.000689	0.0313	CbGeAlD
Quinidine—KCNK6—nervous system—migraine	0.000653	0.0296	CbGeAlD
Quinidine—KCNK6—central nervous system—migraine	0.000629	0.0285	CbGeAlD
Quinidine—KCNK1—trigeminal ganglion—migraine	0.000624	0.0283	CbGeAlD
Quinidine—SCN3A—L1CAM interactions—SCN1A—migraine	0.000558	0.0112	CbGpPWpGaD
Quinidine—KCNK1—brainstem—migraine	0.000552	0.0251	CbGeAlD
Quinidine—SCN2A—L1CAM interactions—SCN1A—migraine	0.000536	0.0108	CbGpPWpGaD
Quinidine—KCNH2—Potassium Channels—KCNK18—migraine	0.000509	0.0102	CbGpPWpGaD
Quinidine—KCNK6—brain—migraine	0.000499	0.0226	CbGeAlD
Quinidine—SCN3A—L1CAM interactions—SCN2A—migraine	0.000475	0.00956	CbGpPWpGaD
Quinidine—KCNK1—cardiovascular system—migraine	0.000451	0.0205	CbGeAlD
Quinidine—SLC22A2—trigeminal ganglion—migraine	0.000441	0.02	CbGeAlD
Quinidine—SCN1A—L1CAM interactions—SCN2A—migraine	0.00044	0.00885	CbGpPWpGaD
Quinidine—KCNK6—Neuronal System—CACNA1A—migraine	0.000423	0.00852	CbGpPWpGaD
Quinidine—SCN1A—brainstem—migraine	0.00041	0.0186	CbGeAlD
Quinidine—SLC22A4—neck—migraine	0.000379	0.0172	CbGeAlD
Quinidine—SCN2A—brainstem—migraine	0.000376	0.0171	CbGeAlD
Quinidine—SCN5A—L1CAM interactions—SCN1A—migraine	0.000363	0.00732	CbGpPWpGaD
Quinidine—KCNK1—Neuronal System—CACNA1A—migraine	0.00036	0.00724	CbGpPWpGaD
Quinidine—SCN5A—L1CAM interactions—SCN2A—migraine	0.000309	0.00622	CbGpPWpGaD
Quinidine—CHRM2—Monoamine GPCRs—HTR1D—migraine	0.000305	0.00615	CbGpPWpGaD
Quinidine—KCNK1—head—migraine	0.000305	0.0139	CbGeAlD
Quinidine—KCNK1—nervous system—migraine	0.000289	0.0131	CbGeAlD
Quinidine—SLC22A8—trigeminal ganglion—migraine	0.000287	0.013	CbGeAlD
Quinidine—CHRM2—Monoamine GPCRs—HTR2B—migraine	0.000284	0.00572	CbGpPWpGaD
Quinidine—KCNK1—central nervous system—migraine	0.000279	0.0126	CbGeAlD
Quinidine—KCNK1—cerebellum—migraine	0.000272	0.0124	CbGeAlD
Quinidine—SCN5A—cardiovascular system—migraine	0.000269	0.0122	CbGeAlD
Quinidine—CHRM2—Amine ligand-binding receptors—HTR1D—migraine	0.000257	0.00517	CbGpPWpGaD
Quinidine—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—migraine	0.000253	0.0051	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000246	0.00496	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000239	0.00481	CbGpPWpGaD
Quinidine—CHRM2—Amine ligand-binding receptors—HTR2B—migraine	0.000239	0.00481	CbGpPWpGaD
Quinidine—KCNH2—trigeminal ganglion—migraine	0.000229	0.0104	CbGeAlD
Quinidine—CHRM2—cardiovascular system—migraine	0.000229	0.0104	CbGeAlD
Quinidine—SCN1A—head—migraine	0.000227	0.0103	CbGeAlD
Quinidine—KCNH2—Neuronal System—KCNK18—migraine	0.000222	0.00447	CbGpPWpGaD
Quinidine—KCNK1—brain—migraine	0.000221	0.01	CbGeAlD
Quinidine—SLC22A5—trigeminal ganglion—migraine	0.000217	0.00983	CbGeAlD
Quinidine—SCN1A—nervous system—migraine	0.000215	0.00975	CbGeAlD
Quinidine—SCN3A—Axon guidance—SCN1A—migraine	0.000211	0.00425	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—HTR3A—migraine	0.00021	0.00422	CbGpPWpGaD
Quinidine—SCN2A—head—migraine	0.000208	0.00944	CbGeAlD
Quinidine—SCN1A—central nervous system—migraine	0.000207	0.00939	CbGeAlD
Quinidine—KCNH2—SIDS Susceptibility Pathways—HTR3A—migraine	0.000203	0.00409	CbGpPWpGaD
Quinidine—SCN2A—Axon guidance—SCN1A—migraine	0.000203	0.00408	CbGpPWpGaD
Quinidine—SCN1A—cerebellum—migraine	0.000202	0.00918	CbGeAlD
Quinidine—SCN2A—nervous system—migraine	0.000197	0.00895	CbGeAlD
Quinidine—SCN2A—central nervous system—migraine	0.00019	0.00862	CbGeAlD
Quinidine—SCN2A—cerebellum—migraine	0.000186	0.00842	CbGeAlD
Quinidine—CHRM2—Monoamine GPCRs—HTR1B—migraine	0.000185	0.00373	CbGpPWpGaD
Quinidine—SCN3A—head—migraine	0.000183	0.0083	CbGeAlD
Quinidine—SCN5A—head—migraine	0.000182	0.00827	CbGeAlD
Quinidine—SCN3A—Axon guidance—SCN2A—migraine	0.000179	0.00361	CbGpPWpGaD
Quinidine—CHRM2—Monoamine GPCRs—HTR1A—migraine	0.000178	0.00359	CbGpPWpGaD
Quinidine—SCN3A—nervous system—migraine	0.000173	0.00787	CbGeAlD
Quinidine—SCN5A—nervous system—migraine	0.000173	0.00784	CbGeAlD
Quinidine—CHRM2—Monoamine GPCRs—HTR2C—migraine	0.000172	0.00346	CbGpPWpGaD
Quinidine—SCN3A—central nervous system—migraine	0.000167	0.00757	CbGeAlD
Quinidine—SCN5A—central nervous system—migraine	0.000166	0.00755	CbGeAlD
Quinidine—SCN1A—Axon guidance—SCN2A—migraine	0.000166	0.00335	CbGpPWpGaD
Quinidine—KCNH2—cardiovascular system—migraine	0.000166	0.00751	CbGeAlD
Quinidine—SCN1A—brain—migraine	0.000164	0.00745	CbGeAlD
Quinidine—SCN3A—cerebellum—migraine	0.000163	0.0074	CbGeAlD
Quinidine—ABCB1—blood vessel—migraine	0.000163	0.00739	CbGeAlD
Quinidine—CYP1A1—Estrogen Receptor Pathway—ESR1—migraine	0.000158	0.00319	CbGpPWpGaD
Quinidine—ORM1—nervous system—migraine	0.000158	0.00716	CbGeAlD
Quinidine—CHRM2—Amine ligand-binding receptors—HTR1B—migraine	0.000155	0.00313	CbGpPWpGaD
Quinidine—CHRM2—head—migraine	0.000155	0.00704	CbGeAlD
Quinidine—SLC22A1—head—migraine	0.000152	0.00692	CbGeAlD
Quinidine—ORM1—central nervous system—migraine	0.000152	0.00689	CbGeAlD
Quinidine—SCN2A—brain—migraine	0.000151	0.00684	CbGeAlD
Quinidine—CHRM2—Monoamine GPCRs—HTR7—migraine	0.000151	0.00303	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—SCN1A—migraine	0.00015	0.00303	CbGpPWpGaD
Quinidine—CHRM2—Amine ligand-binding receptors—HTR1A—migraine	0.00015	0.00301	CbGpPWpGaD
Quinidine—CHRM2—nervous system—migraine	0.000147	0.00668	CbGeAlD
Quinidine—SLCO1A2—head—migraine	0.000147	0.00666	CbGeAlD
Quinidine—SCN2A—Developmental Biology—SCN1A—migraine	0.000145	0.00291	CbGpPWpGaD
Quinidine—CHRM2—Amine ligand-binding receptors—HTR2C—migraine	0.000145	0.00291	CbGpPWpGaD
Quinidine—SLC22A1—nervous system—migraine	0.000145	0.00656	CbGeAlD
Quinidine—SLC22A4—cerebellum—migraine	0.000143	0.00648	CbGeAlD
Quinidine—CHRM2—central nervous system—migraine	0.000142	0.00643	CbGeAlD
Quinidine—SLC22A4—Transmembrane transport of small molecules—TRPM8—migraine	0.00014	0.00283	CbGpPWpGaD
Quinidine—SLC22A8—head—migraine	0.00014	0.00636	CbGeAlD
Quinidine—SLCO1A2—nervous system—migraine	0.000139	0.00631	CbGeAlD
Quinidine—SLC22A1—central nervous system—migraine	0.000139	0.00631	CbGeAlD
Quinidine—SLC22A2—Neuronal System—KCNK18—migraine	0.000139	0.00279	CbGpPWpGaD
Quinidine—SCN5A—Axon guidance—SCN1A—migraine	0.000137	0.00277	CbGpPWpGaD
Quinidine—KCNH2—Hematopoietic Stem Cell Differentiation—FOS—migraine	0.000136	0.00274	CbGpPWpGaD
Quinidine—CYP2B6—cardiovascular system—migraine	0.000136	0.00616	CbGeAlD
Quinidine—CYP2C9—cardiovascular system—migraine	0.000135	0.0061	CbGeAlD
Quinidine—SLCO1A2—central nervous system—migraine	0.000134	0.00608	CbGeAlD
Quinidine—SLC22A8—nervous system—migraine	0.000133	0.00603	CbGeAlD
Quinidine—SCN3A—brain—migraine	0.000132	0.00601	CbGeAlD
Quinidine—Toxic epidermal necrolysis—Topiramate—migraine	0.000132	0.0014	CcSEcCtD
Quinidine—Renal failure—Gabapentin—migraine	0.000132	0.0014	CcSEcCtD
Quinidine—Bradycardia—Timolol—migraine	0.000132	0.00139	CcSEcCtD
Quinidine—SCN5A—brain—migraine	0.000132	0.00599	CbGeAlD
Quinidine—Immune system disorder—Valproic Acid—migraine	0.000132	0.00139	CcSEcCtD
Quinidine—Mediastinal disorder—Valproic Acid—migraine	0.000131	0.00139	CcSEcCtD
Quinidine—Jaundice—Gabapentin—migraine	0.000131	0.00138	CcSEcCtD
Quinidine—SLCO1A2—cerebellum—migraine	0.000131	0.00594	CbGeAlD
Quinidine—Chills—Valproic Acid—migraine	0.000131	0.00138	CcSEcCtD
Quinidine—Dyspnoea—Verapamil—migraine	0.00013	0.00137	CcSEcCtD
Quinidine—Gastrointestinal pain—Propranolol—migraine	0.00013	0.00137	CcSEcCtD
Quinidine—Muscular weakness—Topiramate—migraine	0.00013	0.00137	CcSEcCtD
Quinidine—SLC22A1—Neuronal System—KCNK18—migraine	0.000129	0.0026	CbGpPWpGaD
Quinidine—Sweating—Gabapentin—migraine	0.000129	0.00136	CcSEcCtD
Quinidine—Dizziness—Amitriptyline—migraine	0.000129	0.00136	CcSEcCtD
Quinidine—SCN3A—Developmental Biology—SCN2A—migraine	0.000128	0.00258	CbGpPWpGaD
Quinidine—SLC22A8—central nervous system—migraine	0.000128	0.0058	CbGeAlD
Quinidine—Mental disorder—Valproic Acid—migraine	0.000128	0.00135	CcSEcCtD
Quinidine—CYP2E1—cardiovascular system—migraine	0.000127	0.00579	CbGeAlD
Quinidine—CHRM2—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000127	0.00256	CbGpPWpGaD
Quinidine—Asthma—Topiramate—migraine	0.000127	0.00134	CcSEcCtD
Quinidine—Malnutrition—Valproic Acid—migraine	0.000127	0.00134	CcSEcCtD
Quinidine—CHRM2—Amine ligand-binding receptors—HTR7—migraine	0.000127	0.00255	CbGpPWpGaD
Quinidine—Urticaria—Propranolol—migraine	0.000126	0.00133	CcSEcCtD
Quinidine—Abdominal pain—Propranolol—migraine	0.000126	0.00132	CcSEcCtD
Quinidine—Body temperature increased—Propranolol—migraine	0.000126	0.00132	CcSEcCtD
Quinidine—Visual impairment—Timolol—migraine	0.000125	0.00132	CcSEcCtD
Quinidine—Vomiting—Amitriptyline—migraine	0.000124	0.00131	CcSEcCtD
Quinidine—Angina pectoris—Topiramate—migraine	0.000124	0.0013	CcSEcCtD
Quinidine—CYP2D6—brainstem—migraine	0.000124	0.00561	CbGeAlD
Quinidine—Bradycardia—Gabapentin—migraine	0.000123	0.0013	CcSEcCtD
Quinidine—Rash—Amitriptyline—migraine	0.000123	0.0013	CcSEcCtD
Quinidine—Dermatitis—Amitriptyline—migraine	0.000123	0.0013	CcSEcCtD
Quinidine—Headache—Amitriptyline—migraine	0.000122	0.00129	CcSEcCtD
Quinidine—Eye disorder—Timolol—migraine	0.000121	0.00128	CcSEcCtD
Quinidine—Tinnitus—Timolol—migraine	0.000121	0.00128	CcSEcCtD
Quinidine—Haemorrhage—Gabapentin—migraine	0.000121	0.00127	CcSEcCtD
Quinidine—Hepatitis—Gabapentin—migraine	0.000121	0.00127	CcSEcCtD
Quinidine—Pancytopenia—Topiramate—migraine	0.000121	0.00127	CcSEcCtD
Quinidine—Cardiac disorder—Timolol—migraine	0.00012	0.00127	CcSEcCtD
Quinidine—Feeling abnormal—Verapamil—migraine	0.00012	0.00127	CcSEcCtD
Quinidine—Vision blurred—Valproic Acid—migraine	0.00012	0.00126	CcSEcCtD
Quinidine—Urinary tract disorder—Gabapentin—migraine	0.000119	0.00126	CcSEcCtD
Quinidine—Tremor—Valproic Acid—migraine	0.000119	0.00125	CcSEcCtD
Quinidine—Neutropenia—Topiramate—migraine	0.000119	0.00125	CcSEcCtD
Quinidine—SCN1A—Developmental Biology—SCN2A—migraine	0.000119	0.00239	CbGpPWpGaD
Quinidine—Urethral disorder—Gabapentin—migraine	0.000118	0.00125	CcSEcCtD
Quinidine—Immune system disorder—Timolol—migraine	0.000117	0.00124	CcSEcCtD
Quinidine—SCN3A—Developmental Biology—MEF2D—migraine	0.000117	0.00236	CbGpPWpGaD
Quinidine—Hypersensitivity—Propranolol—migraine	0.000117	0.00123	CcSEcCtD
Quinidine—Mediastinal disorder—Timolol—migraine	0.000117	0.00123	CcSEcCtD
Quinidine—SCN5A—Axon guidance—SCN2A—migraine	0.000117	0.00235	CbGpPWpGaD
Quinidine—Agitation—Valproic Acid—migraine	0.000117	0.00123	CcSEcCtD
Quinidine—Visual impairment—Gabapentin—migraine	0.000116	0.00123	CcSEcCtD
Quinidine—Urticaria—Verapamil—migraine	0.000116	0.00122	CcSEcCtD
Quinidine—SLC22A4—brain—migraine	0.000116	0.00526	CbGeAlD
Quinidine—Angioedema—Valproic Acid—migraine	0.000116	0.00122	CcSEcCtD
Quinidine—Photosensitivity reaction—Topiramate—migraine	0.000116	0.00122	CcSEcCtD
Quinidine—Nausea—Amitriptyline—migraine	0.000116	0.00122	CcSEcCtD
Quinidine—Erythema multiforme—Gabapentin—migraine	0.000114	0.0012	CcSEcCtD
Quinidine—Vertigo—Valproic Acid—migraine	0.000114	0.0012	CcSEcCtD
Quinidine—Asthenia—Propranolol—migraine	0.000114	0.0012	CcSEcCtD
Quinidine—Mental disorder—Timolol—migraine	0.000114	0.0012	CcSEcCtD
Quinidine—Leukopenia—Valproic Acid—migraine	0.000114	0.0012	CcSEcCtD
Quinidine—Erythema—Timolol—migraine	0.000113	0.00119	CcSEcCtD
Quinidine—Malnutrition—Timolol—migraine	0.000113	0.00119	CcSEcCtD
Quinidine—Eye disorder—Gabapentin—migraine	0.000113	0.00119	CcSEcCtD
Quinidine—Tinnitus—Gabapentin—migraine	0.000113	0.00119	CcSEcCtD
Quinidine—CHRM2—brain—migraine	0.000112	0.0051	CbGeAlD
Quinidine—SCN2A—Developmental Biology—MEF2D—migraine	0.000112	0.00226	CbGpPWpGaD
Quinidine—Stevens-Johnson syndrome—Topiramate—migraine	0.000112	0.00118	CcSEcCtD
Quinidine—Cardiac disorder—Gabapentin—migraine	0.000112	0.00118	CcSEcCtD
Quinidine—Palpitations—Valproic Acid—migraine	0.000112	0.00118	CcSEcCtD
Quinidine—KCNH2—head—migraine	0.000112	0.00509	CbGeAlD
Quinidine—Renal failure—Topiramate—migraine	0.000111	0.00117	CcSEcCtD
Quinidine—SLC22A1—brain—migraine	0.00011	0.00501	CbGeAlD
Quinidine—Immune system disorder—Gabapentin—migraine	0.000109	0.00115	CcSEcCtD
Quinidine—Mediastinal disorder—Gabapentin—migraine	0.000109	0.00115	CcSEcCtD
Quinidine—Diarrhoea—Propranolol—migraine	0.000109	0.00115	CcSEcCtD
Quinidine—KCNH2—Neuronal System—CACNA1A—migraine	0.000108	0.00218	CbGpPWpGaD
Quinidine—Chills—Gabapentin—migraine	0.000108	0.00114	CcSEcCtD
Quinidine—SCN1A—Developmental Biology—MEF2D—migraine	0.000108	0.00218	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—HTR3A—migraine	0.000108	0.00218	CbGpPWpGaD
Quinidine—Chest pain—Valproic Acid—migraine	0.000108	0.00114	CcSEcCtD
Quinidine—Myalgia—Valproic Acid—migraine	0.000108	0.00114	CcSEcCtD
Quinidine—Hypersensitivity—Verapamil—migraine	0.000108	0.00113	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000107	0.00113	CcSEcCtD
Quinidine—Vision blurred—Timolol—migraine	0.000106	0.00112	CcSEcCtD
Quinidine—SLC22A4—Transmembrane transport of small molecules—ATP1A2—migraine	0.000106	0.00214	CbGpPWpGaD
Quinidine—SLC22A4—Transmembrane transport of small molecules—ATP1A3—migraine	0.000106	0.00214	CbGpPWpGaD
Quinidine—SLCO1A2—brain—migraine	0.000106	0.00483	CbGeAlD
Quinidine—KCNH2—nervous system—migraine	0.000106	0.00482	CbGeAlD
Quinidine—Mental disorder—Gabapentin—migraine	0.000106	0.00112	CcSEcCtD
Quinidine—Agranulocytosis—Topiramate—migraine	0.000106	0.00111	CcSEcCtD
Quinidine—SLC22A5—Transmembrane transport of small molecules—TRPM8—migraine	0.000106	0.00213	CbGpPWpGaD
Quinidine—CHRM2—Monoamine GPCRs—HTR2A—migraine	0.000105	0.00212	CbGpPWpGaD
Quinidine—Erythema—Gabapentin—migraine	0.000105	0.00111	CcSEcCtD
Quinidine—Malnutrition—Gabapentin—migraine	0.000105	0.00111	CcSEcCtD
Quinidine—Dizziness—Propranolol—migraine	0.000105	0.00111	CcSEcCtD
Quinidine—Asthenia—Verapamil—migraine	0.000105	0.0011	CcSEcCtD
Quinidine—Confusional state—Valproic Acid—migraine	0.000104	0.0011	CcSEcCtD
Quinidine—Oedema—Valproic Acid—migraine	0.000104	0.00109	CcSEcCtD
Quinidine—Bradycardia—Topiramate—migraine	0.000104	0.00109	CcSEcCtD
Quinidine—Pruritus—Verapamil—migraine	0.000103	0.00109	CcSEcCtD
Quinidine—Angioedema—Timolol—migraine	0.000103	0.00109	CcSEcCtD
Quinidine—KCNH2—central nervous system—migraine	0.000102	0.00464	CbGeAlD
Quinidine—Haemoglobin—Topiramate—migraine	0.000102	0.00108	CcSEcCtD
Quinidine—Hepatitis—Topiramate—migraine	0.000102	0.00107	CcSEcCtD
Quinidine—Haemorrhage—Topiramate—migraine	0.000102	0.00107	CcSEcCtD
Quinidine—Nervous system disorder—Valproic Acid—migraine	0.000102	0.00107	CcSEcCtD
Quinidine—SLC22A8—brain—migraine	0.000102	0.00461	CbGeAlD
Quinidine—Vertigo—Timolol—migraine	0.000101	0.00107	CcSEcCtD
Quinidine—Thrombocytopenia—Valproic Acid—migraine	0.000101	0.00107	CcSEcCtD
Quinidine—Syncope—Timolol—migraine	0.000101	0.00107	CcSEcCtD
Quinidine—Tachycardia—Valproic Acid—migraine	0.000101	0.00107	CcSEcCtD
Quinidine—Vomiting—Propranolol—migraine	0.000101	0.00106	CcSEcCtD
Quinidine—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	0.000101	0.00203	CbGpPWpGaD
Quinidine—Skin disorder—Valproic Acid—migraine	0.000101	0.00106	CcSEcCtD
Quinidine—ABCB1—trigeminal ganglion—migraine	0.000101	0.00456	CbGeAlD
Quinidine—Urinary tract disorder—Topiramate—migraine	0.0001	0.00106	CcSEcCtD
Quinidine—Hyperhidrosis—Valproic Acid—migraine	0.0001	0.00106	CcSEcCtD
Quinidine—Rash—Propranolol—migraine	0.0001	0.00106	CcSEcCtD
Quinidine—Dermatitis—Propranolol—migraine	0.0001	0.00105	CcSEcCtD
Quinidine—KCNH2—cerebellum—migraine	0.0001	0.00454	CbGeAlD
Quinidine—Diarrhoea—Verapamil—migraine	9.99e-05	0.00105	CcSEcCtD
Quinidine—Palpitations—Timolol—migraine	9.98e-05	0.00105	CcSEcCtD
Quinidine—Urethral disorder—Topiramate—migraine	9.97e-05	0.00105	CcSEcCtD
Quinidine—SCN5A—SIDS Susceptibility Pathways—HTR1A—migraine	9.96e-05	0.00201	CbGpPWpGaD
Quinidine—Loss of consciousness—Timolol—migraine	9.93e-05	0.00105	CcSEcCtD
Quinidine—Vision blurred—Gabapentin—migraine	9.91e-05	0.00105	CcSEcCtD
Quinidine—Anorexia—Valproic Acid—migraine	9.87e-05	0.00104	CcSEcCtD
Quinidine—Tremor—Gabapentin—migraine	9.86e-05	0.00104	CcSEcCtD
Quinidine—SCN5A—SIDS Susceptibility Pathways—TAC1—migraine	9.81e-05	0.00198	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—SCN1A—migraine	9.8e-05	0.00197	CbGpPWpGaD
Quinidine—Visual impairment—Topiramate—migraine	9.8e-05	0.00103	CcSEcCtD
Quinidine—Hypotension—Valproic Acid—migraine	9.68e-05	0.00102	CcSEcCtD
Quinidine—Agitation—Gabapentin—migraine	9.67e-05	0.00102	CcSEcCtD
Quinidine—Dizziness—Verapamil—migraine	9.66e-05	0.00102	CcSEcCtD
Quinidine—KCNH2—SIDS Susceptibility Pathways—HTR1A—migraine	9.66e-05	0.00195	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—migraine	9.62e-05	0.00194	CbGpPWpGaD
Quinidine—Chest pain—Timolol—migraine	9.62e-05	0.00101	CcSEcCtD
Quinidine—Myalgia—Timolol—migraine	9.62e-05	0.00101	CcSEcCtD
Quinidine—Erythema multiforme—Topiramate—migraine	9.61e-05	0.00101	CcSEcCtD
Quinidine—Angioedema—Gabapentin—migraine	9.61e-05	0.00101	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	9.55e-05	0.00101	CcSEcCtD
Quinidine—SLC22A8—Transmembrane transport of small molecules—TRPM8—migraine	9.55e-05	0.00192	CbGpPWpGaD
Quinidine—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	9.53e-05	0.00192	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—TAC1—migraine	9.51e-05	0.00192	CbGpPWpGaD
Quinidine—Eye disorder—Topiramate—migraine	9.5e-05	0.001	CcSEcCtD
Quinidine—Tinnitus—Topiramate—migraine	9.48e-05	0.000999	CcSEcCtD
Quinidine—CYP1A1—head—migraine	9.47e-05	0.0043	CbGeAlD
Quinidine—Vertigo—Gabapentin—migraine	9.45e-05	0.000996	CcSEcCtD
Quinidine—SLC22A5—cerebellum—migraine	9.45e-05	0.00429	CbGeAlD
Quinidine—Musculoskeletal discomfort—Valproic Acid—migraine	9.44e-05	0.000995	CcSEcCtD
Quinidine—Cardiac disorder—Topiramate—migraine	9.44e-05	0.000995	CcSEcCtD
Quinidine—Flushing—Topiramate—migraine	9.44e-05	0.000995	CcSEcCtD
Quinidine—Syncope—Gabapentin—migraine	9.43e-05	0.000995	CcSEcCtD
Quinidine—Nausea—Propranolol—migraine	9.43e-05	0.000994	CcSEcCtD
Quinidine—Leukopenia—Gabapentin—migraine	9.42e-05	0.000993	CcSEcCtD
Quinidine—KCNH2—SIDS Susceptibility Pathways—SLC6A4—migraine	9.33e-05	0.00188	CbGpPWpGaD
Quinidine—Palpitations—Gabapentin—migraine	9.3e-05	0.00098	CcSEcCtD
Quinidine—Confusional state—Timolol—migraine	9.3e-05	0.00098	CcSEcCtD
Quinidine—Vomiting—Verapamil—migraine	9.29e-05	0.000979	CcSEcCtD
Quinidine—Loss of consciousness—Gabapentin—migraine	9.25e-05	0.000975	CcSEcCtD
Quinidine—Dyspnoea—Valproic Acid—migraine	9.23e-05	0.000973	CcSEcCtD
Quinidine—Oedema—Timolol—migraine	9.22e-05	0.000972	CcSEcCtD
Quinidine—Rash—Verapamil—migraine	9.21e-05	0.000971	CcSEcCtD
Quinidine—Dermatitis—Verapamil—migraine	9.2e-05	0.00097	CcSEcCtD
Quinidine—CYP2B6—head—migraine	9.2e-05	0.00417	CbGeAlD
Quinidine—Immune system disorder—Topiramate—migraine	9.18e-05	0.000968	CcSEcCtD
Quinidine—Mediastinal disorder—Topiramate—migraine	9.16e-05	0.000966	CcSEcCtD
Quinidine—Headache—Verapamil—migraine	9.15e-05	0.000965	CcSEcCtD
Quinidine—Chills—Topiramate—migraine	9.12e-05	0.000962	CcSEcCtD
Quinidine—Convulsion—Gabapentin—migraine	9.11e-05	0.000961	CcSEcCtD
Quinidine—Shock—Timolol—migraine	9.07e-05	0.000956	CcSEcCtD
Quinidine—SLC22A4—Transmembrane transport of small molecules—HTR3A—migraine	9.05e-05	0.00182	CbGpPWpGaD
Quinidine—Nervous system disorder—Timolol—migraine	9.04e-05	0.000953	CcSEcCtD
Quinidine—Decreased appetite—Valproic Acid—migraine	9e-05	0.000949	CcSEcCtD
Quinidine—CYP1A1—nervous system—migraine	8.98e-05	0.00407	CbGeAlD
Quinidine—Chest pain—Gabapentin—migraine	8.96e-05	0.000944	CcSEcCtD
Quinidine—Myalgia—Gabapentin—migraine	8.96e-05	0.000944	CcSEcCtD
Quinidine—Skin disorder—Timolol—migraine	8.96e-05	0.000944	CcSEcCtD
Quinidine—Gastrointestinal disorder—Valproic Acid—migraine	8.94e-05	0.000943	CcSEcCtD
Quinidine—Hyperhidrosis—Timolol—migraine	8.91e-05	0.00094	CcSEcCtD
Quinidine—Mental disorder—Topiramate—migraine	8.91e-05	0.000939	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	8.89e-05	0.000938	CcSEcCtD
Quinidine—CHRM2—Amine ligand-binding receptors—HTR2A—migraine	8.87e-05	0.00179	CbGpPWpGaD
Quinidine—Malnutrition—Topiramate—migraine	8.85e-05	0.000933	CcSEcCtD
Quinidine—Erythema—Topiramate—migraine	8.85e-05	0.000933	CcSEcCtD
Quinidine—SLC22A2—Transmission across Chemical Synapses—CACNA1A—migraine	8.84e-05	0.00178	CbGpPWpGaD
Quinidine—Anorexia—Timolol—migraine	8.79e-05	0.000926	CcSEcCtD
Quinidine—CYP2B6—nervous system—migraine	8.72e-05	0.00396	CbGeAlD
Quinidine—Nausea—Verapamil—migraine	8.68e-05	0.000915	CcSEcCtD
Quinidine—Confusional state—Gabapentin—migraine	8.66e-05	0.000913	CcSEcCtD
Quinidine—CYP1A1—central nervous system—migraine	8.64e-05	0.00392	CbGeAlD
Quinidine—CYP2E1—head—migraine	8.63e-05	0.00392	CbGeAlD
Quinidine—Hypotension—Timolol—migraine	8.62e-05	0.000908	CcSEcCtD
Quinidine—Oedema—Gabapentin—migraine	8.59e-05	0.000905	CcSEcCtD
Quinidine—Feeling abnormal—Valproic Acid—migraine	8.53e-05	0.0009	CcSEcCtD
Quinidine—SLCO1A2—Transmembrane transport of small molecules—TRPM8—migraine	8.48e-05	0.00171	CbGpPWpGaD
Quinidine—Gastrointestinal pain—Valproic Acid—migraine	8.47e-05	0.000893	CcSEcCtD
Quinidine—Shock—Gabapentin—migraine	8.45e-05	0.00089	CcSEcCtD
Quinidine—Nervous system disorder—Gabapentin—migraine	8.42e-05	0.000888	CcSEcCtD
Quinidine—Thrombocytopenia—Gabapentin—migraine	8.41e-05	0.000886	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Timolol—migraine	8.4e-05	0.000886	CcSEcCtD
Quinidine—CYP2B6—central nervous system—migraine	8.4e-05	0.00381	CbGeAlD
Quinidine—Tachycardia—Gabapentin—migraine	8.38e-05	0.000883	CcSEcCtD
Quinidine—Vision blurred—Topiramate—migraine	8.34e-05	0.000879	CcSEcCtD
Quinidine—Skin disorder—Gabapentin—migraine	8.34e-05	0.000879	CcSEcCtD
Quinidine—SCN5A—Developmental Biology—SCN2A—migraine	8.33e-05	0.00168	CbGpPWpGaD
Quinidine—Hyperhidrosis—Gabapentin—migraine	8.3e-05	0.000875	CcSEcCtD
Quinidine—Tremor—Topiramate—migraine	8.29e-05	0.000874	CcSEcCtD
Quinidine—SLC22A1—Transmission across Chemical Synapses—CACNA1A—migraine	8.24e-05	0.00166	CbGpPWpGaD
Quinidine—Urticaria—Valproic Acid—migraine	8.23e-05	0.000867	CcSEcCtD
Quinidine—Dyspnoea—Timolol—migraine	8.22e-05	0.000867	CcSEcCtD
Quinidine—Body temperature increased—Valproic Acid—migraine	8.19e-05	0.000863	CcSEcCtD
Quinidine—Abdominal pain—Valproic Acid—migraine	8.19e-05	0.000863	CcSEcCtD
Quinidine—CYP2E1—nervous system—migraine	8.18e-05	0.00371	CbGeAlD
Quinidine—Anorexia—Gabapentin—migraine	8.18e-05	0.000863	CcSEcCtD
Quinidine—Agitation—Topiramate—migraine	8.13e-05	0.000857	CcSEcCtD
Quinidine—KCNH2—brain—migraine	8.12e-05	0.00369	CbGeAlD
Quinidine—Hypotension—Gabapentin—migraine	8.02e-05	0.000846	CcSEcCtD
Quinidine—Decreased appetite—Timolol—migraine	8.01e-05	0.000845	CcSEcCtD
Quinidine—SLC22A5—Transmembrane transport of small molecules—ATP1A3—migraine	8e-05	0.00161	CbGpPWpGaD
Quinidine—SLC22A5—Transmembrane transport of small molecules—ATP1A2—migraine	8e-05	0.00161	CbGpPWpGaD
Quinidine—Gastrointestinal disorder—Timolol—migraine	7.96e-05	0.000839	CcSEcCtD
Quinidine—Vertigo—Topiramate—migraine	7.95e-05	0.000838	CcSEcCtD
Quinidine—Syncope—Topiramate—migraine	7.94e-05	0.000837	CcSEcCtD
Quinidine—Leukopenia—Topiramate—migraine	7.92e-05	0.000835	CcSEcCtD
Quinidine—CYP2E1—central nervous system—migraine	7.88e-05	0.00358	CbGeAlD
Quinidine—Musculoskeletal discomfort—Gabapentin—migraine	7.82e-05	0.000825	CcSEcCtD
Quinidine—Palpitations—Topiramate—migraine	7.82e-05	0.000825	CcSEcCtD
Quinidine—Loss of consciousness—Topiramate—migraine	7.78e-05	0.00082	CcSEcCtD
Quinidine—ABCC2—Transmembrane transport of small molecules—TRPM8—migraine	7.72e-05	0.00155	CbGpPWpGaD
Quinidine—CYP2E1—cerebellum—migraine	7.7e-05	0.0035	CbGeAlD
Quinidine—SLC22A5—brain—migraine	7.68e-05	0.00348	CbGeAlD
Quinidine—Convulsion—Topiramate—migraine	7.67e-05	0.000808	CcSEcCtD
Quinidine—Dyspnoea—Gabapentin—migraine	7.65e-05	0.000807	CcSEcCtD
Quinidine—Hypersensitivity—Valproic Acid—migraine	7.63e-05	0.000804	CcSEcCtD
Quinidine—SCN5A—Developmental Biology—MEF2D—migraine	7.62e-05	0.00154	CbGpPWpGaD
Quinidine—Feeling abnormal—Timolol—migraine	7.6e-05	0.000801	CcSEcCtD
Quinidine—Gastrointestinal pain—Timolol—migraine	7.54e-05	0.000795	CcSEcCtD
Quinidine—Myalgia—Topiramate—migraine	7.53e-05	0.000794	CcSEcCtD
Quinidine—Chest pain—Topiramate—migraine	7.53e-05	0.000794	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	7.48e-05	0.000789	CcSEcCtD
Quinidine—Decreased appetite—Gabapentin—migraine	7.46e-05	0.000787	CcSEcCtD
Quinidine—CYP2C8—brain—migraine	7.43e-05	0.00337	CbGeAlD
Quinidine—CHRM2—GPCRs, Other—EDNRA—migraine	7.43e-05	0.0015	CbGpPWpGaD
Quinidine—Asthenia—Valproic Acid—migraine	7.43e-05	0.000783	CcSEcCtD
Quinidine—Gastrointestinal disorder—Gabapentin—migraine	7.41e-05	0.000781	CcSEcCtD
Quinidine—Pruritus—Valproic Acid—migraine	7.33e-05	0.000772	CcSEcCtD
Quinidine—Urticaria—Timolol—migraine	7.32e-05	0.000772	CcSEcCtD
Quinidine—CYP1A1—Oxidative Stress—FOS—migraine	7.31e-05	0.00147	CbGpPWpGaD
Quinidine—Abdominal pain—Timolol—migraine	7.29e-05	0.000768	CcSEcCtD
Quinidine—Body temperature increased—Timolol—migraine	7.29e-05	0.000768	CcSEcCtD
Quinidine—Confusional state—Topiramate—migraine	7.28e-05	0.000768	CcSEcCtD
Quinidine—ABCB1—cardiovascular system—migraine	7.26e-05	0.0033	CbGeAlD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—TRPM8—migraine	7.25e-05	0.00146	CbGpPWpGaD
Quinidine—SLC22A8—Transmembrane transport of small molecules—ATP1A2—migraine	7.24e-05	0.00146	CbGpPWpGaD
Quinidine—SLC22A8—Transmembrane transport of small molecules—ATP1A3—migraine	7.24e-05	0.00146	CbGpPWpGaD
Quinidine—Oedema—Topiramate—migraine	7.22e-05	0.000761	CcSEcCtD
Quinidine—ABCC2—NRF2 pathway—SLC6A4—migraine	7.13e-05	0.00144	CbGpPWpGaD
Quinidine—Shock—Topiramate—migraine	7.11e-05	0.000749	CcSEcCtD
Quinidine—Diarrhoea—Valproic Acid—migraine	7.09e-05	0.000747	CcSEcCtD
Quinidine—Nervous system disorder—Topiramate—migraine	7.08e-05	0.000747	CcSEcCtD
Quinidine—Feeling abnormal—Gabapentin—migraine	7.08e-05	0.000746	CcSEcCtD
Quinidine—Thrombocytopenia—Topiramate—migraine	7.07e-05	0.000746	CcSEcCtD
Quinidine—Tachycardia—Topiramate—migraine	7.05e-05	0.000743	CcSEcCtD
Quinidine—Gastrointestinal pain—Gabapentin—migraine	7.02e-05	0.00074	CcSEcCtD
Quinidine—Skin disorder—Topiramate—migraine	7.02e-05	0.00074	CcSEcCtD
Quinidine—SCN5A—SIDS Susceptibility Pathways—BDNF—migraine	6.99e-05	0.00141	CbGpPWpGaD
Quinidine—Hyperhidrosis—Topiramate—migraine	6.98e-05	0.000736	CcSEcCtD
Quinidine—Anorexia—Topiramate—migraine	6.89e-05	0.000726	CcSEcCtD
Quinidine—CYP1A1—brain—migraine	6.86e-05	0.00311	CbGeAlD
Quinidine—Dizziness—Valproic Acid—migraine	6.85e-05	0.000722	CcSEcCtD
Quinidine—CYP2D6—head—migraine	6.84e-05	0.0031	CbGeAlD
Quinidine—Urticaria—Gabapentin—migraine	6.82e-05	0.000719	CcSEcCtD
Quinidine—SLC22A5—Transmembrane transport of small molecules—HTR3A—migraine	6.8e-05	0.00137	CbGpPWpGaD
Quinidine—Hypersensitivity—Timolol—migraine	6.79e-05	0.000716	CcSEcCtD
Quinidine—Body temperature increased—Gabapentin—migraine	6.79e-05	0.000716	CcSEcCtD
Quinidine—Abdominal pain—Gabapentin—migraine	6.79e-05	0.000716	CcSEcCtD
Quinidine—KCNH2—SIDS Susceptibility Pathways—BDNF—migraine	6.77e-05	0.00136	CbGpPWpGaD
Quinidine—SLC22A2—Neuronal System—CACNA1A—migraine	6.77e-05	0.00136	CbGpPWpGaD
Quinidine—Hypotension—Topiramate—migraine	6.75e-05	0.000712	CcSEcCtD
Quinidine—CHRM2—GPCRs, Other—HTR7—migraine	6.69e-05	0.00135	CbGpPWpGaD
Quinidine—CYP2B6—brain—migraine	6.67e-05	0.00303	CbGeAlD
Quinidine—SLC22A2—Transmembrane transport of small molecules—TRPM8—migraine	6.64e-05	0.00134	CbGpPWpGaD
Quinidine—Asthenia—Timolol—migraine	6.61e-05	0.000697	CcSEcCtD
Quinidine—CYP3A4—nervous system—migraine	6.59e-05	0.00299	CbGeAlD
Quinidine—Vomiting—Valproic Acid—migraine	6.58e-05	0.000694	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Topiramate—migraine	6.58e-05	0.000694	CcSEcCtD
Quinidine—Rash—Valproic Acid—migraine	6.53e-05	0.000688	CcSEcCtD
Quinidine—Dermatitis—Valproic Acid—migraine	6.52e-05	0.000688	CcSEcCtD
Quinidine—Pruritus—Timolol—migraine	6.52e-05	0.000688	CcSEcCtD
Quinidine—Headache—Valproic Acid—migraine	6.49e-05	0.000684	CcSEcCtD
Quinidine—CYP2D6—nervous system—migraine	6.48e-05	0.00294	CbGeAlD
Quinidine—Dyspnoea—Topiramate—migraine	6.44e-05	0.000679	CcSEcCtD
Quinidine—SLCO1A2—Transmembrane transport of small molecules—ATP1A2—migraine	6.43e-05	0.00129	CbGpPWpGaD
Quinidine—SLCO1A2—Transmembrane transport of small molecules—ATP1A3—migraine	6.43e-05	0.00129	CbGpPWpGaD
Quinidine—CHRM2—G alpha (i) signalling events—HTR1D—migraine	6.35e-05	0.00128	CbGpPWpGaD
Quinidine—CYP3A4—central nervous system—migraine	6.34e-05	0.00288	CbGeAlD
Quinidine—Hypersensitivity—Gabapentin—migraine	6.33e-05	0.000667	CcSEcCtD
Quinidine—SLC22A1—Neuronal System—CACNA1A—migraine	6.31e-05	0.00127	CbGpPWpGaD
Quinidine—Diarrhoea—Timolol—migraine	6.31e-05	0.000665	CcSEcCtD
Quinidine—Decreased appetite—Topiramate—migraine	6.28e-05	0.000662	CcSEcCtD
Quinidine—CYP2E1—brain—migraine	6.26e-05	0.00284	CbGeAlD
Quinidine—CYP2D6—central nervous system—migraine	6.24e-05	0.00283	CbGeAlD
Quinidine—Gastrointestinal disorder—Topiramate—migraine	6.24e-05	0.000657	CcSEcCtD
Quinidine—SLC22A1—Transmembrane transport of small molecules—TRPM8—migraine	6.19e-05	0.00125	CbGpPWpGaD
Quinidine—Asthenia—Gabapentin—migraine	6.16e-05	0.000649	CcSEcCtD
Quinidine—SLC22A8—Transmembrane transport of small molecules—HTR3A—migraine	6.15e-05	0.00124	CbGpPWpGaD
Quinidine—Nausea—Valproic Acid—migraine	6.15e-05	0.000649	CcSEcCtD
Quinidine—CYP2D6—cerebellum—migraine	6.1e-05	0.00277	CbGeAlD
Quinidine—Dizziness—Timolol—migraine	6.1e-05	0.000643	CcSEcCtD
Quinidine—Pruritus—Gabapentin—migraine	6.07e-05	0.00064	CcSEcCtD
Quinidine—Feeling abnormal—Topiramate—migraine	5.95e-05	0.000627	CcSEcCtD
Quinidine—Gastrointestinal pain—Topiramate—migraine	5.91e-05	0.000623	CcSEcCtD
Quinidine—SCN5A—SIDS Susceptibility Pathways—HTR2A—migraine	5.9e-05	0.00119	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	5.89e-05	0.00119	CbGpPWpGaD
Quinidine—Diarrhoea—Gabapentin—migraine	5.87e-05	0.000619	CcSEcCtD
Quinidine—Vomiting—Timolol—migraine	5.86e-05	0.000618	CcSEcCtD
Quinidine—ABCC2—Transmembrane transport of small molecules—ATP1A3—migraine	5.85e-05	0.00118	CbGpPWpGaD
Quinidine—ABCC2—Transmembrane transport of small molecules—ATP1A2—migraine	5.85e-05	0.00118	CbGpPWpGaD
Quinidine—Rash—Timolol—migraine	5.81e-05	0.000613	CcSEcCtD
Quinidine—Dermatitis—Timolol—migraine	5.81e-05	0.000612	CcSEcCtD
Quinidine—Headache—Timolol—migraine	5.78e-05	0.000609	CcSEcCtD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—migraine	5.76e-05	0.00116	CbGpPWpGaD
Quinidine—Urticaria—Topiramate—migraine	5.74e-05	0.000605	CcSEcCtD
Quinidine—KCNH2—SIDS Susceptibility Pathways—HTR2A—migraine	5.72e-05	0.00115	CbGpPWpGaD
Quinidine—Abdominal pain—Topiramate—migraine	5.71e-05	0.000602	CcSEcCtD
Quinidine—Body temperature increased—Topiramate—migraine	5.71e-05	0.000602	CcSEcCtD
Quinidine—Dizziness—Gabapentin—migraine	5.68e-05	0.000599	CcSEcCtD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—ATP1A3—migraine	5.49e-05	0.00111	CbGpPWpGaD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—ATP1A2—migraine	5.49e-05	0.00111	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	5.48e-05	0.0011	CbGpPWpGaD
Quinidine—Nausea—Timolol—migraine	5.48e-05	0.000577	CcSEcCtD
Quinidine—SLCO1A2—Transmembrane transport of small molecules—HTR3A—migraine	5.46e-05	0.0011	CbGpPWpGaD
Quinidine—Vomiting—Gabapentin—migraine	5.46e-05	0.000575	CcSEcCtD
Quinidine—Rash—Gabapentin—migraine	5.41e-05	0.000571	CcSEcCtD
Quinidine—Dermatitis—Gabapentin—migraine	5.41e-05	0.00057	CcSEcCtD
Quinidine—ABCC2—NRF2 pathway—TGFBR2—migraine	5.38e-05	0.00108	CbGpPWpGaD
Quinidine—Headache—Gabapentin—migraine	5.38e-05	0.000567	CcSEcCtD
Quinidine—Hypersensitivity—Topiramate—migraine	5.32e-05	0.000561	CcSEcCtD
Quinidine—CHRM2—GPCR ligand binding—RAMP1—migraine	5.29e-05	0.00107	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CALCRL—migraine	5.29e-05	0.00107	CbGpPWpGaD
Quinidine—Asthenia—Topiramate—migraine	5.18e-05	0.000546	CcSEcCtD
Quinidine—CHRM2—SIDS Susceptibility Pathways—HTR1A—migraine	5.14e-05	0.00103	CbGpPWpGaD
Quinidine—Pruritus—Topiramate—migraine	5.11e-05	0.000539	CcSEcCtD
Quinidine—Nausea—Gabapentin—migraine	5.1e-05	0.000538	CcSEcCtD
Quinidine—CHRM2—SIDS Susceptibility Pathways—TAC1—migraine	5.06e-05	0.00102	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	5.05e-05	0.00102	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—ATP1A3—migraine	5.04e-05	0.00101	CbGpPWpGaD
Quinidine—SLC22A2—Transmembrane transport of small molecules—ATP1A2—migraine	5.04e-05	0.00101	CbGpPWpGaD
Quinidine—ABCC2—Transmembrane transport of small molecules—HTR3A—migraine	4.97e-05	0.001	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—SLC6A4—migraine	4.96e-05	0.001	CbGpPWpGaD
Quinidine—CYP2D6—brain—migraine	4.95e-05	0.00225	CbGeAlD
Quinidine—Diarrhoea—Topiramate—migraine	4.94e-05	0.000521	CcSEcCtD
Quinidine—ABCB1—head—migraine	4.92e-05	0.00223	CbGeAlD
Quinidine—Dizziness—Topiramate—migraine	4.78e-05	0.000504	CcSEcCtD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	4.69e-05	0.000945	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—ATP1A2—migraine	4.69e-05	0.000945	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—ATP1A3—migraine	4.69e-05	0.000945	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Other—HTR2A—migraine	4.69e-05	0.000944	CbGpPWpGaD
Quinidine—SLCO1B1—Transmembrane transport of small molecules—HTR3A—migraine	4.67e-05	0.000941	CbGpPWpGaD
Quinidine—ABCB1—nervous system—migraine	4.66e-05	0.00212	CbGeAlD
Quinidine—Vomiting—Topiramate—migraine	4.59e-05	0.000484	CcSEcCtD
Quinidine—Rash—Topiramate—migraine	4.55e-05	0.00048	CcSEcCtD
Quinidine—Dermatitis—Topiramate—migraine	4.55e-05	0.00048	CcSEcCtD
Quinidine—Headache—Topiramate—migraine	4.53e-05	0.000477	CcSEcCtD
Quinidine—ABCB1—central nervous system—migraine	4.49e-05	0.00204	CbGeAlD
Quinidine—ABCB1—cerebellum—migraine	4.39e-05	0.00199	CbGeAlD
Quinidine—Nausea—Topiramate—migraine	4.29e-05	0.000452	CcSEcCtD
Quinidine—SLC22A2—Transmembrane transport of small molecules—HTR3A—migraine	4.28e-05	0.000862	CbGpPWpGaD
Quinidine—SLC22A1—Transmembrane transport of small molecules—HTR3A—migraine	3.99e-05	0.000804	CbGpPWpGaD
Quinidine—CHRM2—G alpha (i) signalling events—HTR1B—migraine	3.85e-05	0.000775	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—HTR1D—migraine	3.84e-05	0.000774	CbGpPWpGaD
Quinidine—CHRM2—G alpha (i) signalling events—HTR1A—migraine	3.7e-05	0.000746	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	3.67e-05	0.000739	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	3.63e-05	0.000731	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—BDNF—migraine	3.6e-05	0.000726	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—HTR2B—migraine	3.57e-05	0.00072	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	3.57e-05	0.000719	CbGpPWpGaD
Quinidine—ABCB1—brain—migraine	3.56e-05	0.00162	CbGeAlD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	3.44e-05	0.000692	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	3.32e-05	0.000668	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	3.23e-05	0.00065	CbGpPWpGaD
Quinidine—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	3.11e-05	0.000625	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	3.06e-05	0.000616	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—HTR2A—migraine	3.04e-05	0.000613	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—RAMP1—migraine	2.99e-05	0.000602	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CALCRL—migraine	2.99e-05	0.000602	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	2.94e-05	0.000593	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	2.91e-05	0.000585	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	2.9e-05	0.000584	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	2.9e-05	0.000584	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	2.84e-05	0.000573	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	2.79e-05	0.000562	CbGpPWpGaD
Quinidine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—migraine	2.79e-05	0.000562	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	2.77e-05	0.000557	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	2.75e-05	0.000554	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	2.75e-05	0.000554	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—RAMP1—migraine	2.72e-05	0.000547	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CALCRL—migraine	2.72e-05	0.000547	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—CACNA1A—migraine	2.61e-05	0.000525	CbGpPWpGaD
Quinidine—SCN5A—SIDS Susceptibility Pathways—TNF—migraine	2.54e-05	0.000511	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	2.49e-05	0.000502	CbGpPWpGaD
Quinidine—KCNH2—SIDS Susceptibility Pathways—TNF—migraine	2.46e-05	0.000496	CbGpPWpGaD
Quinidine—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	2.34e-05	0.000471	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—HTR1B—migraine	2.33e-05	0.000469	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—HTR1A—migraine	2.24e-05	0.000452	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—TAC1—migraine	2.21e-05	0.000445	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—NPS—migraine	2.21e-05	0.000445	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—CACNA1A—migraine	2.18e-05	0.000438	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—HTR1D—migraine	2.17e-05	0.000438	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—HTR2C—migraine	2.17e-05	0.000436	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—EDNRA—migraine	2.11e-05	0.000424	CbGpPWpGaD
Quinidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	2.04e-05	0.00041	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—CALCA—migraine	2.03e-05	0.000408	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—HTR2B—migraine	2.02e-05	0.000407	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HTR1D—migraine	1.97e-05	0.000397	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	1.96e-05	0.000395	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—HTR7—migraine	1.9e-05	0.000382	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—CACNA1A—migraine	1.86e-05	0.000375	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HTR2B—migraine	1.83e-05	0.000369	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	1.78e-05	0.000358	CbGpPWpGaD
Quinidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	1.78e-05	0.000358	CbGpPWpGaD
Quinidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	1.74e-05	0.000351	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—CACNA1A—migraine	1.71e-05	0.000344	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—CACNA1A—migraine	1.7e-05	0.000343	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—RAMP1—migraine	1.6e-05	0.000323	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CALCRL—migraine	1.6e-05	0.000323	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—CACNA1A—migraine	1.59e-05	0.00032	CbGpPWpGaD
Quinidine—SCN3A—Developmental Biology—TNF—migraine	1.55e-05	0.000312	CbGpPWpGaD
Quinidine—SCN2A—Developmental Biology—TNF—migraine	1.49e-05	0.0003	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.47e-05	0.000297	CbGpPWpGaD
Quinidine—ABCB1—Allograft Rejection—TNF—migraine	1.45e-05	0.000291	CbGpPWpGaD
Quinidine—SCN1A—Developmental Biology—TNF—migraine	1.44e-05	0.000289	CbGpPWpGaD
Quinidine—CHRM2—GPCR ligand binding—HTR2A—migraine	1.33e-05	0.000268	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—HTR1B—migraine	1.32e-05	0.000265	CbGpPWpGaD
Quinidine—CHRM2—SIDS Susceptibility Pathways—TNF—migraine	1.31e-05	0.000264	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—HTR1A—migraine	1.27e-05	0.000255	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—CACNA1A—migraine	1.26e-05	0.000254	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—TAC1—migraine	1.25e-05	0.000251	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—NPS—migraine	1.25e-05	0.000251	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—CACNA1A—migraine	1.24e-05	0.000249	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—HTR2C—migraine	1.22e-05	0.000246	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HTR1B—migraine	1.2e-05	0.000241	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—EDNRA—migraine	1.19e-05	0.00024	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—CACNA1A—migraine	1.17e-05	0.000235	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HTR1D—migraine	1.17e-05	0.000235	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HTR1A—migraine	1.15e-05	0.000232	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—CALCA—migraine	1.15e-05	0.000231	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—NPS—migraine	1.13e-05	0.000228	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—TAC1—migraine	1.13e-05	0.000228	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HTR2C—migraine	1.11e-05	0.000224	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HTR2B—migraine	1.08e-05	0.000218	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—EDNRA—migraine	1.08e-05	0.000218	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—HTR7—migraine	1.07e-05	0.000216	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—CACNA1A—migraine	1.07e-05	0.000215	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—CALCA—migraine	1.04e-05	0.00021	CbGpPWpGaD
Quinidine—SCN5A—Developmental Biology—TNF—migraine	1.01e-05	0.000203	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HTR7—migraine	9.73e-06	0.000196	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—LRP1—migraine	9.54e-06	0.000192	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—CACNA1A—migraine	9.31e-06	0.000188	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—CACNA1A—migraine	8.78e-06	0.000177	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—CACNA1A—migraine	8.7e-06	0.000175	CbGpPWpGaD
Quinidine—ABCB11—Metabolism—MTHFR—migraine	8.62e-06	0.000174	CbGpPWpGaD
Quinidine—CHRM2—GPCR downstream signaling—HTR2A—migraine	7.51e-06	0.000151	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—CACNA1A—migraine	7.44e-06	0.00015	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NOTCH4—migraine	7.32e-06	0.000147	CbGpPWpGaD
Quinidine—SLCO1A2—Metabolism—MTHFR—migraine	7.2e-06	0.000145	CbGpPWpGaD
Quinidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	7.14e-06	0.000144	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HTR1B—migraine	7.06e-06	0.000142	CbGpPWpGaD
Quinidine—CHRM2—Signaling by GPCR—HTR2A—migraine	6.82e-06	0.000137	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HTR1A—migraine	6.8e-06	0.000137	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TAC1—migraine	6.69e-06	0.000135	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NPS—migraine	6.69e-06	0.000135	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—PGR—migraine	6.69e-06	0.000135	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HTR2C—migraine	6.56e-06	0.000132	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—EDNRA—migraine	6.39e-06	0.000129	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—NOTCH3—migraine	6.22e-06	0.000125	CbGpPWpGaD
Quinidine—SLCO1B1—Metabolism—MTHFR—migraine	6.15e-06	0.000124	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—CALCA—migraine	6.15e-06	0.000124	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HTR7—migraine	5.75e-06	0.000116	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—CACNA1A—migraine	5.74e-06	0.000116	CbGpPWpGaD
Quinidine—CYP3A7—Metabolism—MTHFR—migraine	5.65e-06	0.000114	CbGpPWpGaD
Quinidine—SLC22A2—Metabolism—MTHFR—migraine	5.64e-06	0.000114	CbGpPWpGaD
Quinidine—SLC22A1—Metabolism—MTHFR—migraine	5.26e-06	0.000106	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—TGFBR2—migraine	4.95e-06	9.97e-05	CbGpPWpGaD
Quinidine—CYP2B6—Metabolism—MTHFR—migraine	4.18e-06	8.41e-05	CbGpPWpGaD
Quinidine—CYP2E1—Metabolism—MTHFR—migraine	4.09e-06	8.24e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—HTR2A—migraine	4.03e-06	8.11e-05	CbGpPWpGaD
Quinidine—CYP1A1—Metabolism—MTHFR—migraine	3.86e-06	7.77e-05	CbGpPWpGaD
Quinidine—CHRM2—Signaling Pathways—ESR1—migraine	3.57e-06	7.2e-05	CbGpPWpGaD
Quinidine—CYP2C8—Metabolism—MTHFR—migraine	3.54e-06	7.12e-05	CbGpPWpGaD
Quinidine—ABCB1—Metabolism—MTHFR—migraine	3.08e-06	6.21e-05	CbGpPWpGaD
Quinidine—CYP2D6—Metabolism—MTHFR—migraine	2.9e-06	5.85e-05	CbGpPWpGaD
Quinidine—CYP2C9—Metabolism—MTHFR—migraine	2.88e-06	5.8e-05	CbGpPWpGaD
Quinidine—CYP1A2—Metabolism—MTHFR—migraine	2.46e-06	4.95e-05	CbGpPWpGaD
Quinidine—CYP3A4—Metabolism—MTHFR—migraine	1.9e-06	3.82e-05	CbGpPWpGaD
